Auteurs
Analysis
Canada
Racine
Analysis
Canada
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur Pittsburgh - Analysis (Canada)

Index « Auteurs » - entrée « Mark A. Socinski »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mark A. Rubin < Mark A. Socinski < Mark A. Wainberg  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000014 (2015) Corey J. Langer [États-Unis] ; Vera Hirsh [Canada] ; Amy Ko [États-Unis] ; Markus F. Renschler [États-Unis] ; Mark A. Socinski [États-Unis]Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: analysis of safety and efficacy in patients with renal impairment.
000060 (2014) Charles Butts [Canada] ; Mark A. Socinski [États-Unis] ; Paul L. Mitchell [Australie] ; Nick Thatcher [Royaume-Uni] ; Libor Havel [République tchèque] ; Maciej Krzakowski [Pologne] ; Sergiusz Nawrocki [Pologne] ; Tudor-Eliade Ciuleanu [Roumanie] ; Lionel Bosquée [Belgique] ; José Manuel Trigo [Espagne] ; Alexander Spira [États-Unis] ; Lise Tremblay [Canada] ; Jan Nyman [Suède] ; Rodryg Ramlau [Pologne] ; Gun Wickart-Johansson [Suède] ; Peter Ellis [Canada] ; Oleg Gladkov [Russie] ; José Rodrigues Pereira [Brésil] ; Wilfried Ernst Erich Eberhardt [Allemagne] ; Christoph Helwig [Allemagne] ; Andreas Schröder [Allemagne] ; Frances A. Shepherd [Canada]Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Adult
2Aged
2Aged, 80 and over
2Carcinoma, Non-Small-Cell Lung (drug therapy)
2Carcinoma, Non-Small-Cell Lung (pathology)
2Female
2Humans
2Lung Neoplasms (drug therapy)
2Lung Neoplasms (pathology)
2Male
2Middle Aged
1Albumins (administration & dosage)
1Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
1Cancer Vaccines (therapeutic use)
1Carboplatin (administration & dosage)
1Carcinoma, Non-Small-Cell Lung (mortality)
1Chemoradiotherapy
1Disease-Free Survival
1Double-Blind Method
1Lung Neoplasms (mortality)
1Membrane Glycoproteins (therapeutic use)
1Neoplasm Staging
1Paclitaxel (administration & dosage)
1Renal Insufficiency (complications)
1Renal Insufficiency (physiopathology)
1Survival Rate
1Treatment Outcome
1Young Adult

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Canada/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Mark A. Socinski" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Mark A. Socinski" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Mark A. Socinski
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021